Previous close | 2.8000 |
Open | 2.8000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 185.00 |
Expiry date | 2024-08-16 |
Day's range | 2.8000 - 2.8000 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Key developments include a major asset sale and a focus on pharmaceutical innovation, despite a challenging financial quarter.
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and Invitae (OTC:NVTAQ), a leading medical genetics company, announced today that the United States Bankruptcy Court has approved the previously announced bid by Labcorp to acquire assets of Invitae.
On April 29, 2024, Peter Wilkinson, Senior Vice President and Chief Accounting Officer at Laboratory Corp of America Holdings (NYSE:LH), sold 2,439 shares of the company.